Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $657.95 million. The enterprise value is $458.48 million.
| Market Cap | 657.95M |
| Enterprise Value | 458.48M |
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 59.12 million shares outstanding. The number of shares has increased by 19.19% in one year.
| Current Share Class | 59.12M |
| Shares Outstanding | 59.12M |
| Shares Change (YoY) | +19.19% |
| Shares Change (QoQ) | +2.60% |
| Owned by Insiders (%) | 1.20% |
| Owned by Institutions (%) | 64.04% |
| Float | 54.96M |
Valuation Ratios
The trailing PE ratio is 5.61 and the forward PE ratio is 14.38.
| PE Ratio | 5.61 |
| Forward PE | 14.38 |
| PS Ratio | 5.38 |
| Forward PS | 4.05 |
| PB Ratio | 3.20 |
| P/TBV Ratio | 3.37 |
| P/FCF Ratio | 54.85 |
| P/OCF Ratio | 51.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.00, with an EV/FCF ratio of 38.22.
| EV / Earnings | 3.92 |
| EV / Sales | 3.75 |
| EV / EBITDA | 36.00 |
| EV / EBIT | 46.03 |
| EV / FCF | 38.22 |
Financial Position
The company has a current ratio of 4.89, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.89 |
| Quick Ratio | 4.74 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.10 |
| Interest Coverage | 1.29 |
Financial Efficiency
Return on equity (ROE) is 100.65% and return on invested capital (ROIC) is 55.90%.
| Return on Equity (ROE) | 100.65% |
| Return on Assets (ROA) | 2.76% |
| Return on Invested Capital (ROIC) | 55.90% |
| Return on Capital Employed (ROCE) | 4.30% |
| Weighted Average Cost of Capital (WACC) | 10.18% |
| Revenue Per Employee | $2.00M |
| Profits Per Employee | $1.92M |
| Employee Count | 61 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 7.00 |
Taxes
In the past 12 months, ZVRA has paid $9.18 million in taxes.
| Income Tax | 9.18M |
| Effective Tax Rate | 6.88% |
Stock Price Statistics
The stock price has increased by +48.20% in the last 52 weeks. The beta is 0.88, so ZVRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | +48.20% |
| 50-Day Moving Average | 9.80 |
| 200-Day Moving Average | 9.43 |
| Relative Strength Index (RSI) | 64.41 |
| Average Volume (20 Days) | 1,059,031 |
Short Selling Information
The latest short interest is 4.78 million, so 8.08% of the outstanding shares have been sold short.
| Short Interest | 4.78M |
| Short Previous Month | 4.44M |
| Short % of Shares Out | 8.08% |
| Short % of Float | 8.69% |
| Short Ratio (days to cover) | 5.88 |
Income Statement
In the last 12 months, ZVRA had revenue of $122.29 million and earned $117.00 million in profits. Earnings per share was $1.98.
| Revenue | 122.29M |
| Gross Profit | 105.26M |
| Operating Income | 9.96M |
| Pretax Income | 133.40M |
| Net Income | 117.00M |
| EBITDA | 12.73M |
| EBIT | 9.96M |
| Earnings Per Share (EPS) | $1.98 |
Balance Sheet
The company has $200.62 million in cash and $1.15 million in debt, with a net cash position of $199.47 million or $3.37 per share.
| Cash & Cash Equivalents | 200.62M |
| Total Debt | 1.15M |
| Net Cash | 199.47M |
| Net Cash Per Share | $3.37 |
| Equity (Book Value) | 205.80M |
| Book Value Per Share | 3.48 |
| Working Capital | 182.94M |
Cash Flow
In the last 12 months, operating cash flow was $12.77 million and capital expenditures -$771,000, giving a free cash flow of $12.00 million.
| Operating Cash Flow | 12.77M |
| Capital Expenditures | -771,000 |
| Depreciation & Amortization | 2.77M |
| Net Borrowing | -60.09M |
| Free Cash Flow | 12.00M |
| FCF Per Share | $0.20 |
Margins
Gross margin is 86.07%, with operating and profit margins of 8.15% and 101.58%.
| Gross Margin | 86.07% |
| Operating Margin | 8.15% |
| Pretax Margin | 109.09% |
| Profit Margin | 101.58% |
| EBITDA Margin | 10.41% |
| EBIT Margin | 8.15% |
| FCF Margin | 9.81% |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.19% |
| Shareholder Yield | -19.19% |
| Earnings Yield | 17.78% |
| FCF Yield | 1.82% |
Analyst Forecast
The average price target for ZVRA is $23.33, which is 109.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.33 |
| Price Target Difference | 109.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 19.04% |
| EPS Growth Forecast (5Y) | 14.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 1:16.
| Last Split Date | Dec 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
ZVRA has an Altman Z-Score of 3.63 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.63 |
| Piotroski F-Score | 6 |